Back
SAB Biotherapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SABS
SAB Biotherapeutics, Inc.
Last Price:
$3.62
Seasonality Move:
-52.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and SABS is experiencing slight selling pressure.
SAB Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Sell |
| 20-day SMA: | 3.81 | Sell |
| 50-day SMA: | 3.52 | Buy |
| 200-day SMA: | 2.35 | Buy |
| 8-day EMA: | 3.81 | Sell |
| 20-day EMA: | 3.79 | Sell |
| 50-day EMA: | 3.49 | Buy |
| 200-day EMA: | 2.82 | Buy |
SAB Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 47.03 | Sell |
| Chaikin Money Flow: | -46140 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.7 - 3.98) | Sell |
| Bollinger Bands (100): | (2.13 - 3.59) | Buy |
SAB Biotherapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SAB Biotherapeutics, Inc. Stock
Is SAB Biotherapeutics, Inc. Stock a Buy?
-
SAB Biotherapeutics, Inc. share price is 3.65 while SABS 8-day simple moving average is 3.86, which is a Sell signal.
-
The stock price of SABS is 3.65 while SAB Biotherapeutics, Inc. 20-day SMA is 3.81, which makes it a Sell.
-
SAB Biotherapeutics, Inc. 50-day simple moving average is 3.52 while SABS share price is 3.65, making it a Buy technically.
-
SABS stock price is 3.65 and SAB Biotherapeutics, Inc. 200-day simple moving average is 2.35, creating a Buy signal.
SABS Technical Analysis vs Fundamental Analysis
Sell
44
SAB Biotherapeutics, Inc. (SABS)
is a Sell
Is SAB Biotherapeutics, Inc. a Buy or a Sell?
-
SAB Biotherapeutics, Inc. stock is rated a SellThe current SAB Biotherapeutics, Inc. [SABS] share price is $3.65. The Score for SABS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
SAB Biotherapeutics, Inc. Stock Info
Market Cap:
173.8M
Price in USD:
3.65
Share Volume:
112.1K
SAB Biotherapeutics, Inc. 52-Week Range
52-Week High:
6.60
52-Week Low:
1.00
Sell
44
SAB Biotherapeutics, Inc. (SABS)
is a Sell
SAB Biotherapeutics, Inc. Share Price Forecast
-
What is the SAB Biotherapeutics, Inc. stock price today?The SAB Biotherapeutics, Inc. stock price is 3.65 USD today.
-
Will SABS stock go up or go down?SAB Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is SAB Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SAB Biotherapeutics, Inc. is overvalued.
Is SAB Biotherapeutics, Inc. Stock a Buy?
-
SAB Biotherapeutics, Inc. share price is 3.65 while SABS 8-day exponential moving average is 3.81, which is a Sell signal.
-
The stock price of SABS is 3.65 while SAB Biotherapeutics, Inc. 20-day EMA is 3.79, which makes it a Sell.
-
SAB Biotherapeutics, Inc. 50-day exponential moving average is 3.49 while SABS share price is 3.65, making it a Buy technically.
-
SABS stock price is 3.65 and SAB Biotherapeutics, Inc. 200-day simple moving average is 2.82, creating a Buy signal.
Fundamental Analysis of SAB Biotherapeutics, Inc.
Is SAB Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Technical Analysis of SAB Biotherapeutics, Inc.
Should I short SAB Biotherapeutics, Inc. stock?
-
SABS Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting SAB Biotherapeutics, Inc. is a Buy
-
SAB Biotherapeutics, Inc. Relative Strength Index (RSI) is 47.03, which suggest SAB Biotherapeutics, Inc. is oversold
-
The Bollinger Bands (25) for SAB Biotherapeutics, Inc. is (3.7 - 3.98), which suggest SAB Biotherapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for SAB Biotherapeutics, Inc. is (2.13 - 3.59), which suggest SAB Biotherapeutics, Inc. is a Buy
* SAB Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.